ID XYLI_PSEPU Reviewed; 264 AA. AC P49155; DT 01-FEB-1996, integrated into UniProtKB/Swiss-Prot. DT 01-FEB-1996, sequence version 1. DT 10-JUN-2026, entry version 90. DE RecName: Full=2-oxo-3-hexenedioate decarboxylase {ECO:0000305}; DE EC=4.1.1.77 {ECO:0000269|PubMed:2681159}; DE AltName: Full=4-oxalocrotonate decarboxylase {ECO:0000303|PubMed:2681159}; DE Short=4-OD {ECO:0000303|PubMed:10651637}; GN Name=xylI {ECO:0000303|PubMed:2681159}; OS Pseudomonas putida (Arthrobacter siderocapsulatus). OG Plasmid TOL pWW0 {ECO:0000303|PubMed:8510667}. OC Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria; OC Pseudomonadales; Pseudomonadaceae; Pseudomonas. OX NCBI_TaxID=303; RN [1] {ECO:0000312|EMBL:AAA25693.1} RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=ATCC 33015 / DSM 3931 / JCM 6156 / NCIMB 12182 / mt-2; RX PubMed=8510667; DOI=10.1007/bf00281605; RA Harayama S., Rekik M.; RT "Comparison of the nucleotide sequences of the meta-cleavage pathway genes RT of TOL plasmid pWW0 from Pseudomonas putida with other meta-cleavage genes RT suggests that both single and multiple nucleotide substitutions contribute RT to enzyme evolution."; RL Mol. Gen. Genet. 239:81-89(1993). RN [2] RP FUNCTION, CATALYTIC ACTIVITY, COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES, AND RP SUBUNIT. RC STRAIN=ATCC 33015 / DSM 3931 / JCM 6156 / NCIMB 12182 / mt-2; RX PubMed=2681159; DOI=10.1128/jb.171.11.6251-6258.1989; RA Harayama S., Rekik M., Ngai K.L., Ornston L.N.; RT "Physically associated enzymes produce and metabolize 2-hydroxy-2,4- RT dienoate, a chemically unstable intermediate formed in catechol metabolism RT via meta cleavage in Pseudomonas putida."; RL J. Bacteriol. 171:6251-6258(1989). RN [3] RP FUNCTION, COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES, AND SUBUNIT. RC STRAIN=ATCC 33015 / DSM 3931 / JCM 6156 / NCIMB 12182 / mt-2; RX PubMed=10651637; DOI=10.1021/bi9918902; RA Stanley T.M., Johnson W.H. Jr., Burks E.A., Whitman C.P., Hwang C.C., RA Cook P.F.; RT "Expression and stereochemical and isotope effect studies of active 4- RT oxalocrotonate decarboxylase."; RL Biochemistry 39:718-726(2000). RN [4] RP ERRATUM OF PUBMED:10651637. RX PubMed=10727248; DOI=10.1021/bi005106l; RA Stanley T.M., Johnson W.H. Jr., Burks E.A., Whitman C.P., Hwang C.C., RA Cook P.F.; RL Biochemistry 39:3514-3514(2000). CC -!- FUNCTION: Decarboxylase involved in catechol metabolism CC (PubMed:10651637, PubMed:2681159). Part of a complex that catalyzes the CC conversion of 2-oxohex-3-enedioate to 4-hydroxy-2-oxopentanoate, via CC the intermediate 2-hydroxypenta-2,4-dienoate (PubMed:10651637, CC PubMed:2681159). This subunit catalyzes the first step, the conversion CC of 2-oxohex-3-enedioate to 2-hydroxypenta-2,4-dienoate, which is CC unstable and can spontaneously form 2-oxopent-4-enoate CC (PubMed:10651637, PubMed:2681159). The enol form of the substrate CC cannot be used by the enzyme (PubMed:2681159). CC {ECO:0000269|PubMed:10651637, ECO:0000269|PubMed:2681159}. CC -!- CATALYTIC ACTIVITY: CC Reaction=(3E)-2-oxohex-3-enedioate + H(+) = 2-oxopent-4-enoate + CO2; CC Xref=Rhea:RHEA:24260, ChEBI:CHEBI:11641, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:16526, ChEBI:CHEBI:64908; EC=4.1.1.77; CC Evidence={ECO:0000269|PubMed:2681159}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:24261; CC Evidence={ECO:0000269|PubMed:2681159}; CC -!- COFACTOR: CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; CC Evidence={ECO:0000269|PubMed:10651637, ECO:0000269|PubMed:2681159}; CC Name=Mn(2+); Xref=ChEBI:CHEBI:29035; CC Evidence={ECO:0000269|PubMed:10651637}; CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=15 uM for 2-oxohex-3-enedioate {ECO:0000269|PubMed:2681159}; CC KM=6.6 uM for 2-oxohex-3-enedioate {ECO:0000269|PubMed:10651637}; CC Vmax=51 umol/min/mg enzyme {ECO:0000269|PubMed:2681159}; CC Note=kcat is 68 sec(-1). {ECO:0000269|PubMed:10651637}; CC pH dependence: CC Optimum pH is 6.5. {ECO:0000269|PubMed:2681159}; CC -!- PATHWAY: Aromatic compound metabolism; catechol degradation. CC {ECO:0000305|PubMed:10651637, ECO:0000305|PubMed:2681159}. CC -!- SUBUNIT: Part of a complex composed of a decarboxylase (XylI) and an CC hydratase (XylJ) (PubMed:10651637, PubMed:2681159). Formation of a CC complex between the decarboxylase and the hydratase may assure CC efficient transformation of the unstable intermediate in vivo CC (PubMed:2681159). {ECO:0000269|PubMed:10651637, CC ECO:0000269|PubMed:2681159}. CC -!- SIMILARITY: Belongs to the hydratase/decarboxylase family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M94186; AAA25693.1; -; Genomic_DNA. DR PIR; S35224; S35224. DR RefSeq; WP_011005903.1; NC_003350.1. DR AlphaFoldDB; P49155; -. DR SMR; P49155; -. DR BioCyc; MetaCyc:MONOMER-12752; -. DR UniPathway; UPA00750; -. DR GO; GO:0005737; C:cytoplasm; IEA:TreeGrafter. DR GO; GO:0008684; F:2-oxopent-4-enoate hydratase activity; IEA:TreeGrafter. DR GO; GO:0047437; F:4-oxalocrotonate decarboxylase activity; IEA:UniProtKB-EC. DR GO; GO:0042203; P:toluene catabolic process; IEA:UniProtKB-UniPathway. DR Gene3D; 3.90.850.10; Fumarylacetoacetase-like, C-terminal domain; 1. DR InterPro; IPR017630; 4-oxalocrotonate_decarboxylase. DR InterPro; IPR011234; Fumarylacetoacetase-like_C. DR InterPro; IPR036663; Fumarylacetoacetase_C_sf. DR InterPro; IPR050772; Hydratase-Decarb/MhpD_sf. DR NCBIfam; TIGR03218; catechol_dmpH; 1. DR PANTHER; PTHR30143:SF0; 2-KETO-4-PENTENOATE HYDRATASE; 1. DR PANTHER; PTHR30143; ACID HYDRATASE; 1. DR Pfam; PF01557; FAA_hydrolase; 1. DR SUPFAM; SSF56529; FAH; 1. PE 1: Evidence at protein level; KW Aromatic hydrocarbons catabolism; Lyase; Magnesium; Manganese; Plasmid. FT CHAIN 1..264 FT /note="2-oxo-3-hexenedioate decarboxylase" FT /id="PRO_0000066054" SQ SEQUENCE 264 AA; 28510 MW; DDF93ACC910722F9 CRC64; MNRTLNREQV LALAEHIENA ELQAHDIHKV TNDYPEMTFA DAYTIQWEIR RRKEERGNKI VGLKMGLTSW AKMAQMGVET PIYGFLADYF SVPDGGVVDC SKLIHPKIEA EIAVVTKAPL VGPGCHIGDV IAAVDYVIPT VEVIDSRYEN FKFDLISVVA DNASSTRYIT GGRMANLEDV DLRTLGVVME KNGEVVELGA GAAVLGHPLS SVAMLANLLA ERGEHIPAGT FIMTGGITAA VAVAPGDNIT VRYQGLGSVS ARFV //